| scholarly article | Q13442814 |
| P50 | author | Esben Thyssen Vestergaard | Q54417010 |
| Jens Juul Holst | Q28373106 | ||
| Niels Moller | Q40020458 | ||
| Jens Otto Lunde Jørgensen | Q40020467 | ||
| P2093 | author name string | Søren Nielsen | |
| Ole Schmitz | |||
| Jakob Gjedsted | |||
| Christian Born Djurhuus | |||
| P2860 | cites work | Ghrelin is a growth-hormone-releasing acylated peptide from stomach | Q22010951 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 438-444 | |
| P577 | publication date | 2007-11-27 | |
| P1433 | published in | The Journal of Clinical Endocrinology and Metabolism | Q3186902 |
| P1476 | title | Acute effects of ghrelin administration on glucose and lipid metabolism | |
| P478 | volume | 93 |
| Q51387546 | A practical guide for the stabilization of acylghrelin in human blood collections |
| Q30353107 | Acute peripheral metabolic effects of intraarterial ghrelin infusion in healthy young men. |
| Q42437302 | Acute peripheral tissue effects of ghrelin on interstitial levels of glucose, glycerol, and lactate: a microdialysis study in healthy human subjects |
| Q38960873 | Acyl Ghrelin Induces Insulin Resistance Independently of GH, Cortisol, and Free Fatty Acids |
| Q91844907 | Acylated and unacylated ghrelin directly regulate ß-3 stimulated lipid turnover in rodent subcutaneous and visceral adipose tissue ex vivo but not in vivo |
| Q33896080 | Acylated and unacylated ghrelin do not directly stimulate glucose transport in isolated rodent skeletal muscle. |
| Q33419419 | Anamorelin for patients with cancer cachexia: an integrated analysis of two phase 2, randomised, placebo-controlled, double-blind trials |
| Q34223469 | CRF type 2 receptors mediate the metabolic effects of ghrelin in C2C12 cells |
| Q42576339 | Characterization of the insulin sensitivity of ghrelin receptor KO mice using glycemic clamps |
| Q51300189 | Chronic administration of ghrelin regulates plasma glucose and normalizes insulin levels following fasting hyperglycemia and hyperinsulinemia. |
| Q34002674 | Clinical development of ghrelin axis-derived molecules for cancer cachexia treatment |
| Q34335494 | Clinical review: The human experience with ghrelin administration |
| Q37349579 | Dietary stimulation of the endogenous somatotropic axis in weaner and grower-finisher pigs using medium chain triglycerides and cysteamine hydrochloride |
| Q39786249 | Discovery of PF-5190457, a Potent, Selective, and Orally Bioavailable Ghrelin Receptor Inverse Agonist Clinical Candidate |
| Q48301999 | Effect of Resected Gastric Volume on Ghrelin and GLP-1 Plasma Levels: a Prospective Study |
| Q42672818 | Effect of ghrelin on glucose-insulin homeostasis: therapeutic implications. |
| Q34200880 | Effects of delayed gastric emptying on postprandial glucose kinetics, insulin sensitivity, and β-cell function |
| Q36063018 | Effects of sleep restriction on glucose control and insulin secretion during diet-induced weight loss |
| Q84265335 | First-phase insulin secretion, insulin sensitivity, ghrelin, GLP-1, and PYY changes 72 h after sleeve gastrectomy in obese diabetic patients: the gastric hypothesis |
| Q99551839 | Ghrelin ameliorates tumor-induced adipose tissue atrophy and inflammation via Ghrelin receptor-dependent and -independent pathways |
| Q57791096 | Ghrelin forms in the modulation of energy balance and metabolism |
| Q41934541 | Ghrelin infusion in humans induces acute insulin resistance and lipolysis independent of growth hormone signaling |
| Q48060884 | Ghrelin receptor inverse agonists as a novel therapeutic approach against obesity-related metabolic disease. |
| Q64068031 | Ghrelin stimulates fatty acid oxidation and inhibits lipolysis in isolated muscle from male rats |
| Q92385181 | Ghrelin's Relationship to Blood Glucose |
| Q36928023 | Ghrelin- and GH-induced insulin resistance: no association with retinol-binding protein-4. |
| Q38341934 | Implications of ghrelin and hexarelin in diabetes and diabetes-associated heart diseases |
| Q26852874 | Interrelationships between ghrelin, insulin and glucose homeostasis: Physiological relevance |
| Q30252857 | Metabolic responses to exogenous ghrelin in obesity and early after Roux-en-Y gastric bypass in humans |
| Q39233644 | Molecules implicated in glucose homeostasis are differentially expressed in the trachea of lean and obese Zucker rats |
| Q47800514 | Pharmacokinetics and pharmacodynamics of PF-05190457: The first oral ghrelin receptor inverse agonist to be profiled in healthy subjects. |
| Q36797357 | Pharmacological characterization of the first in class clinical candidate PF-05190457: a selective ghrelin receptor competitive antagonist with inverse agonism that increases vagal afferent firing and glucose-dependent insulin secretion ex vivo |
| Q38965089 | Physiological and molecular responses to bariatric surgery: markers or mechanisms underlying T2DM resolution? |
| Q50673188 | ROMANA 3: a phase 3 safety extension study of anamorelin in advanced non-small-cell lung cancer (NSCLC) patients with cachexia |
| Q61796715 | Sleeve Gastrectomy and Roux-en-Y Gastric Bypass Achieve Similar Early Improvements in Beta-cell Function in Obese Patients with Type 2 Diabetes |
| Q42970087 | The metabolic response to the activation of the beta-adrenergic receptor by salbutamol is amplified by acylated ghrelin |
| Q28080912 | The role of gut adaptation in the potent effects of multiple bariatric surgeries on obesity and diabetes |
| Q36060564 | The β-cell GHSR and downstream cAMP/TRPM2 signaling account for insulinostatic and glycemic effects of ghrelin |
| Q98566238 | Unacylated ghrelin stimulates fatty acid oxidation to protect skeletal muscle against palmitate-induced impairment of insulin action in lean but not high-fat fed rats |
Search more.